Journal · Updated 2026-08-11
The GLP-1 Telehealth Intake: What Happens, What to Answer Honestly, and the Red Flags
By the GLP1ProviderFinder Research Desk · Medically reviewed by Dr. A. Goher, MD · Last reviewed 2026-08-11 · How we verify
The short answer
A legitimate intake runs one of two shapes — an asynchronous questionnaire reviewed by a state-licensed clinician, or a synchronous video visit — and both should cover the same ground: medical history, current medications (every one), weight and goal context, and the class's specific screening items. Five answers are non-negotiable honesty, because they're the contraindication and coordination screen: personal or family history of medullary thyroid carcinoma or MEN 2 (the boxed-warning contraindication), pancreatitis history, pregnancy, trying, or breastfeeding, every glucose-lowering medication (the re-dosing interactions), and the full medication list including lithium, levothyroxine, and blood-pressure agents. Lying to get approved doesn't defeat the system — it defeats the only safety layer between a checkout page and a weekly injection. The inverse also holds: an intake that never asks these questions has told you exactly what its clinical layer weighs.
The red flags, and the good-intake tells
Rubber-stamp signs that grade a program in one screen: guaranteed approval advertised before any question is asked (screening with a guaranteed outcome isn't screening); no medication-history questions or a form that lets you skip them; no identity or state verification (licensure matching is the legal spine of telehealth — its absence is structural, not casual); instant prescriptions with no evidence a clinician reviewed anything; and upsell-shaped medicine — an intake whose only branching logic routes you toward more expensive add-ons. Good-intake tells, equally visible: dose-history questions if you've used GLP-1s before (continuity matters), a mechanism to reach the prescriber with questions before paying, clear identification of who reviewed your case and their licensure, and — the tell this site weights heaviest — willingness to name the pharmacy when asked, since the intake is exactly where the verification checklist's first question lands. Use the intake as a two-way interview: they're screening you for safety; you're screening them for the difference between a medical practice and a checkout flow wearing one's clothes.
Questions people ask
What questions does a GLP-1 telehealth intake ask?
Legitimate intakes cover medical history, the full medication list, weight context, and the class's screening items: thyroid cancer (MTC/MEN 2) history, pancreatitis, pregnancy/breastfeeding status, and glucose-lowering medications. Async questionnaires and video visits are both standard — the coverage matters, not the format.
What happens if I'm not honest on the intake?
You defeat the only safety layer in the process: the contraindication screen (MTC/MEN 2, pancreatitis, pregnancy) and the interaction coordination (insulin, sulfonylureas, lithium) exist to prevent specific, documented harms. A prescription obtained by omission is a risk purchased, not a system beaten.
What are the signs of a rubber-stamp telehealth program?
Guaranteed approval advertised upfront, no medication-history questions, no identity/state verification, instant prescriptions with no clinician trace, and intakes whose only logic is upselling. The positive tell: a program that asks real questions and names its pharmacy when you ask yours.
This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.